Efficacy of immunotherapy in KRAS-mutant advanced NSCLC: A real-world study in a Chinese population.
Peng L, Guo J, Kong L, Huang Y, Tang N, Zhang J, Wang M, He X, Li Z, Peng Y, Wang Z, Han X.
Peng L, et al. Among authors: wang z, wang m.
Front Oncol. 2023 Jan 19;12:1070761. doi: 10.3389/fonc.2022.1070761. eCollection 2022.
Front Oncol. 2023.
PMID: 36741723
Free PMC article.